Literature DB >> 7889292

Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats.

A Morán1, C Velasco, T Salvador, M L Martín, L San Román.   

Abstract

1. A study was made of the effects of 5-hydroxytryptamine (5-HT) on pressor response induced in vivo by electrical stimulation of the sympathetic outflow from the spinal cord of pithed rats. All animals had been pretreated with atropine. Intravenous infusion of 5-hydroxytryptamine at doses of 10 and 20 micrograms kg-1 min-1 reduced the pressor effects obtained by electrical stimulation at intervals of 10 min over the 1 h of infusion. 2. This inhibitory action of 5-HT was depressed by cyproheptadine and methiothepin but was not modified by ketanserin or MDL-72222. By contrast, the inhibitory action of 5-HT was lost in pithed rats that had been pretreated with exogenous noradrenaline. 3. The 5-HT1 receptor agonist 5-carboxamidotryptamine (5-CT) caused an inhibition of the pressor response, whereas the 5-HT3 receptor agonist, 1-phenylbiguanide, produced a variable but significant increase in the pressor response. The 5-HT2 receptor agonist, m-CPP, did not modify the pressor sympathetic response. 4. Our results suggest that 5-hydroxytryptamine interferes with sympathetic neurotransmission by inhibiting pressor effects as a result of stimulation of the complete sympathetic outflow, and that this inhibition is mainly through a presynaptic 5-HT1 mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889292      PMCID: PMC1510480          DOI: 10.1111/j.1476-5381.1994.tb17147.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  Serotonin agonists and antagonists in experimental hypertension.

Authors:  P R Saxena; G R Bolt; K M Dhasmana
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 2.  Cardiovascular effects of serotonin.

Authors:  P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.

Authors:  J E Leysen; P Van Gompel; W Gommeren
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

4.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

Review 5.  Serotonin and vascular responses.

Authors:  N K Hollenberg
Journal:  Annu Rev Pharmacol Toxicol       Date:  1988       Impact factor: 13.820

6.  Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.

Authors:  K Gradin; A Pettersson; S Hjorth; T Hedner; L E Arvidsson; B Persson
Journal:  J Pharm Pharmacol       Date:  1985-04       Impact factor: 3.765

Review 7.  Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?

Authors:  P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

8.  The central site of the sympatho-inhibitory action of 5-hydroxytryptamine in the cat.

Authors:  J H Coote; D W Dalton; W Fenuik; P P Humphrey
Journal:  Neuropharmacology       Date:  1987 Feb-Mar       Impact factor: 5.250

9.  Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.

Authors:  M Göthert; E Schlicker; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

10.  Neuronal 5-HT receptors in the periphery.

Authors:  J R Fozard
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

View more
  4 in total

1.  5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation.

Authors:  Emma S Darios; Susan M Barman; Hakan S Orer; Shaun F Morrison; Robert P Davis; Bridget M Seitz; Robert Burnett; Stephanie W Watts
Journal:  Eur J Pharmacol       Date:  2015-02-28       Impact factor: 4.432

2.  Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.

Authors:  Mónica García; Asunción Morán; Elena Calama; Maria Luisa Martín; Mariette Barthelmebs; Luis San Román
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats.

Authors:  José Ángel García-Pedraza; Oswaldo Hernández-Abreu; Asunción Morán; José Carretero; Mónica García-Domingo; Carlos M Villalón
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

4.  The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function.

Authors:  Olivia A Lin; Zubair A Karim; Hari Priya Vemana; Enma V P Espinosa; Fadi T Khasawneh
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.